AU2001237046A1 - Inhibition of mal-1, the keratinocyte lipid binding protein - Google Patents
Inhibition of mal-1, the keratinocyte lipid binding proteinInfo
- Publication number
- AU2001237046A1 AU2001237046A1 AU2001237046A AU3704601A AU2001237046A1 AU 2001237046 A1 AU2001237046 A1 AU 2001237046A1 AU 2001237046 A AU2001237046 A AU 2001237046A AU 3704601 A AU3704601 A AU 3704601A AU 2001237046 A1 AU2001237046 A1 AU 2001237046A1
- Authority
- AU
- Australia
- Prior art keywords
- mal
- inhibition
- binding protein
- lipid binding
- keratinocyte lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Marine Sciences & Fisheries (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18310600P | 2000-02-17 | 2000-02-17 | |
US60183106 | 2000-02-17 | ||
PCT/US2001/005019 WO2001060384A1 (en) | 2000-02-17 | 2001-02-16 | Inhibition of mal-1, the keratinocyte lipid binding protein |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001237046A1 true AU2001237046A1 (en) | 2001-08-27 |
Family
ID=22671465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001237046A Abandoned AU2001237046A1 (en) | 2000-02-17 | 2001-02-16 | Inhibition of mal-1, the keratinocyte lipid binding protein |
Country Status (3)
Country | Link |
---|---|
US (1) | US7056662B2 (en) |
AU (1) | AU2001237046A1 (en) |
WO (1) | WO2001060384A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1512752A1 (en) * | 2003-09-08 | 2005-03-09 | Centre National De La Recherche Scientifique (Cnrs) | Method of diagnosis of obesity |
WO2008033890A2 (en) | 2006-09-12 | 2008-03-20 | Beth Israel Deaconess Medical Center, Inc. | Compositions containing alpha-1-antitrypsin and methods for use |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU781295B2 (en) | 1999-02-12 | 2005-05-12 | President And Fellows Of Harvard College | Inhibiting formation of atherosclerotic lesions |
-
2001
- 2001-02-16 AU AU2001237046A patent/AU2001237046A1/en not_active Abandoned
- 2001-02-16 US US09/788,074 patent/US7056662B2/en not_active Expired - Lifetime
- 2001-02-16 WO PCT/US2001/005019 patent/WO2001060384A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20010044110A1 (en) | 2001-11-22 |
WO2001060384A1 (en) | 2001-08-23 |
US7056662B2 (en) | 2006-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001232799A1 (en) | Protein c derivatives | |
AU2001273164A1 (en) | Membrane associated protein zupari | |
AU2001294192A1 (en) | Solid preparations | |
AU2001238359A1 (en) | Membranes | |
AU3404901A (en) | Constructive nanolithography | |
AU2001284362A1 (en) | Resorcinol derivatives | |
AU3942901A (en) | Navigational aid | |
AU2001280590A1 (en) | 5-substituted 2-aryl-4-pyrimidinones | |
AU2001293538A1 (en) | Novel protein tyrosine phosphatase inhibitor | |
AU2001220281A1 (en) | Rollerboard for road-skiing | |
AU2001269888A1 (en) | Protein phosphatases | |
AU2001283012A1 (en) | Protein phosphatases | |
AU2001287914A1 (en) | Protein kinase regulation | |
AU2001295582A1 (en) | Tumour-related antigens | |
AU2001292870A1 (en) | Protein phosphatases | |
AU2001288102A1 (en) | Solid preparations | |
AU2002221132A1 (en) | Novel antibody | |
AU2002223788A1 (en) | Tannages | |
AU4431601A (en) | Protein kinase assay | |
AU2001272427A1 (en) | Solid preparations | |
AU2002216100A1 (en) | Dormancy - induced mycobacterium proteins | |
AU2001237046A1 (en) | Inhibition of mal-1, the keratinocyte lipid binding protein | |
AU2002239747A1 (en) | Cystoskeleton-associated proteins | |
AU2001244863A1 (en) | Apoptin-associating protein | |
AU2002217962A1 (en) | Death domain proteins |